First Citizens Bank & Trust’s AngioDynamics ANGO Stock Holding History

First Citizens Bank & Trust’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,388	Closed	-$259K	–	427
2021 Q4	$259K	Sell	9,388 -714	-7%	-$19.7K	0.01%	338
2021 Q3	$262K	Sell	10,102 -236	-2%	-$6.31K	0.01%	330
2021 Q2	$281K	Buy	10,338 +795	+8%	+$19.4K	0.01%	313
2021 Q1	$223K	Sell	9,543 -734	-7%	-$14.8K	0.01%	361
2020 Q4	$158K	Sell	10,277 -4,273	-29%	-$54.2K	0.01%	367
2020 Q3	$175K	Sell	14,550 -1,195	-8%	-$11.3K	0.01%	355
2020 Q2	$160K	Buy	15,745 +4,419	+39%	+$45.5K	0.01%	376
2020 Q1	$118K	Buy	+11,326	New	+$142K	0.01%	304

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

First Citizens Bank & Trust's ANGO Position: Q1 2022 in Review

First Citizens Bank & Trust sold out of AngioDynamics (ANGO) in Q1 2022, closing a stake of 9,388 shares — an estimated $259K sold.

First Citizens Bank & Trust first reported a position in ANGO in Q1 2020 and held it in 8 quarters. The position peaked at $281K in Q2 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

First Citizens Bank & Trust reported no remaining AngioDynamics position as of Q1 2022 after selling out during the quarter.
First Citizens Bank & Trust sold 9,388 AngioDynamics shares in Q1 2022, an estimated $259K.
First Citizens Bank & Trust first reported a position in AngioDynamics in Q1 2020 and held it in 8 quarters.
First Citizens Bank & Trust's AngioDynamics position peaked at $281K in Q2 2021.
144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on First Citizens Bank & Trust's 13F filing for Q1 2022, filed 26 Apr 2022.